Your session is about to expire
← Back to Search
Corticosteroid
Topical Treatment for Eczema
N/A
Recruiting
Led By Steven R Feldman, MD, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of skin dermatitis
Age > 9
Must not have
Patients without the diagnosis of skin dermatitis
Body Surface Area (BSA) affected <2%
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7
Awards & highlights
No Placebo-Only Group
Summary
This trial highlights the problem of patients not taking their medications as prescribed. About half of people with chronic diseases do not follow their treatment plans, leading to high hospital costs. This issue is common in dermat
Who is the study for?
This trial is for individuals with atopic dermatitis, commonly known as eczema. It's designed to help those who struggle with following their medication regimen consistently.
What is being tested?
The study is testing the effectiveness of a mobile app in improving treatment adherence compared to standard care. Participants will also be shown how to apply triamcinolone cream properly.
What are the potential side effects?
While the trial focuses on app usage and demonstration, side effects may relate primarily to the use of triamcinolone cream which can include skin irritation, dryness, or infections.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with skin dermatitis.
Select...
I am older than 9 years.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have skin dermatitis.
Select...
Less than 2% of my body is affected by my condition.
Select...
I cannot come back for a follow-up in one week.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 7
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Amount of Topical Medication Dispensed - Demonstration Group
Amount of Topical Medication Dispensed - Mobile Application Group
Amount of Topical Medication Dispensed - Standard of Care Group
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Written/verbal instructions onlyExperimental Treatment1 Intervention
Standard of care written/verbal instructions only
Group II: Mobile ApplicationExperimental Treatment1 Intervention
Additional mobile application that provides instructions to apply the medication (triamcinolone cream)
Group III: DemonstrationActive Control1 Intervention
Observe a live demonstration instructing how to dispense 1 fingertip unit (FTU) of medication (triamcinolone cream) per 1% body surface area
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,401 Previous Clinical Trials
2,460,275 Total Patients Enrolled
Steven R Feldman, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences
14 Previous Clinical Trials
573 Total Patients Enrolled